CRBP vs NIO · $102.3M cap vs rev $12.51B
Corbus Pharmaceuticals Holding (CRBP) versus Nio Inc Class A ADR (NIO) — a side-by-side from cached financials, not a winner call.
Corbus Pharmaceuticals Holding (CRBP) is a biotechnology company listed on US.
Nio Inc Class A ADR (NIO) is a auto manufacturers company listed on US. It is led by Bin Li.
CRBP does not have a complete income-statement cache yet.
Latest reported NIO revenue for 2025-12-31 was $12.51B. Net income was -$2.14B. Revenue was up 38.9% from 2024-12-31 to 2025-12-31. NIO currently screens at market cap $7.61B.
CRBP currently screens at market cap $102.3M. NIO currently screens at market cap $7.61B.
Not investment advice. Open the CRBP and NIO stock pages for the full models.
Not investment advice.